[Lecture Notes in Computer Science] Modeling Decisions for Artificial Intelligence Volume 3558 || Qualitative Reasoning Model for Tradeoff Analysis
- 作者Torra, Vicenç; Narukawa, Yasuo; Miyamoto, Sadaaki
- 文件大小376.92KB
- 发表时间2005
- DOI10.1007/11526018_11
- 页码99-109
Valuing Chimeric Antigen Receptor T-Cell Therapy: Current Evidence, Uncertainties, and Payment ImplicationsWhittington, Melanie D.; McQueen, R. Brett; Campbell, Jonathan D. · Journal of Clinical Oncology · 2019
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysisWhittington, Melanie D.; McQueen, R. Brett; Ollendorf, Daniel A.; Tice, Jeffrey A.; Chapman, Richard H.; Pearson, Steven D.; Campbell, Jonathan D. · Annals of Allergy, Asthma & Immunology · 2017
Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic EvaluationsMcQueen, R. Brett; Sheehan, Danielle N.; Whittington, Melanie D.; van Boven, Job F. M.; Campbell, Jonathan D. · PharmacoEconomics · 2018
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell LymphomaWhittington, Melanie D.; McQueen, R. Brett; Ollendorf, Daniel A.; Kumar, Varun M.; Chapman, Richard H.; Tice, Jeffrey A.; Pearson, Steven D.; Campbell, Jonathan D. · JAMA Network Open · 2019
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory LeukemiaWhittington, Melanie D.; McQueen, R. Brett; Ollendorf, Daniel A.; Kumar, Varun M.; Chapman, Richard H.; Tice, Jeffrey A.; Pearson, Steven D.; Campbell, Jonathan D. · JAMA Pediatrics · 2018
Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness AnalysisWhittington, Melanie D.; McQueen, R. Brett; Ollendorf, Daniel A.; Chapman, Richard H.; Kumar, Varun M.; Synnott, Patricia G.; Agboola, Foluso; Campbell, Jonathan D. · Journal of Managed Care & Specialty Pharmacy · 2019
Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”McQueen, R. Brett; Whittington, Melanie D.; Chapman, Rick H.; Kumar, Varun M.; Campbell, Jonathan D. · PharmacoEconomics · 2019
Informing the UninformedTait, Alan R.; Voepel-Lewis, Terri; Nair, Vijayan N.; Narisetty, Naveen N.; Fagerlin, Angela · JAMA Pediatrics · 2013
Flaxseed in Pediatric HyperlipidemiaWong, Helen; Chahal, Nita; Manlhiot, Cedric; Niedra, Elizabeth; McCrindle, Brian W. · JAMA Pediatrics · 2013
Less Is MoreTamma, Pranita D.; Turnbull, Alison E.; Harris, Anthony D.; Milstone, Aaron M.; Hsu, Alice J.; Cosgrove, Sara E. · JAMA Pediatrics · 2013
Knowledge Is PowerWald, Anna · JAMA Pediatrics · 2013
Quality Measurements in PediatricsLorch, Scott A. · JAMA Pediatrics · 2013
Improved Neonatal Outcomes With ProbioticsShane, Andi L.; Deshpande, Girish C.; Merenstein, Dan · JAMA Pediatrics · 2013
Clostridium difficile Infection in ChildrenSammons, Julia Shaklee; Toltzis, Philip; Zaoutis, Theoklis E. · JAMA Pediatrics · 2013
Celiac DiseaseGuandalini, Stefano; Assiri, Asaad · JAMA Pediatrics · 2014